Sapientiae Institute - Educational and Research Centre in Assisted Reproduction, São Paulo, SP, Brazil.
Reprod Biomed Online. 2012 Apr;24(4):420-3. doi: 10.1016/j.rbmo.2012.01.007. Epub 2012 Jan 24.
The aim of this prospective randomized study was to determine if the use of intracytoplasmic morphologically selected sperm injection (IMSI) is associated with gender incidence. Couples who underwent IVF-preimplantation genetic screening (PGS) cycles, as a result of advanced maternal age, were randomly allocated into two groups: intracytoplasmic sperm injection (ICSI; n=80) or intracytoplasmic morphologically selected sperm injection (IMSI; n=80). The incidences of genders were compared between ICSI- and IMSI-derived embryos. Considering all the biopsied embryos were characterized as normal for sex chromosome, the results showed that IMSI results in a significantly higher incidence of female embryos as compared with ICSI (65.1% versus 54.0%, respectively, P=0.0277). After analysing only euploid embryos for the eight selected chromosomes, a significantly higher incidence of XX embryos derived from IMSI was also observed compared with ICSI cycles (66.9% versus 52.5%, respectively, P=0.0322). This result was confirmed by logistic regression, which demonstrated a nearly 2-fold increase in euploid XX embryos derived from spermatozoa selected by high magnification (OR 1.83, 95% CI 1.05-3.35, P=0.032). A higher proportion of morphologically normal spermatozoa analysed under high magnification seem to carry the X chromosome. The aim of this study was to determine if the use of intracytoplasmic morphologically selected sperm injection (IMSI) is associated with gender incidence. Couples who underwent IVF with preimplantation genetic screening, as a result of advanced maternal age, were randomly allocated into two groups: intracytoplasmic sperm injection (ICSI; n=80) or intracytoplasmic morphologically selected sperm injection (IMSI; n=80). The incidences of genders were compared between ICSI- and IMSI-derived embryos. Our results showed that a significantly higher incidence of female embryos derived from IMSI compared with ICSI cycles (66.9% versus 52.5%, respectively, P=0.0322). This result was confirmed by logistic regression, which demonstrated a nearly 2-fold increase in female embryos derived from sperm selected by high magnification (OR 1.83, 95% CI 1.05-3.35, P=0.032). A higher proportion of morphologically normal spermatozoa analysed under high magnification seem to carry the X chromosome.
本前瞻性随机研究的目的是确定胞浆内形态选择精子注射(IMSI)的使用是否与性别发生率有关。由于高龄产妇,接受体外受精-胚胎植入前遗传筛查(PGS)周期的夫妇被随机分配到两组:胞浆内单精子注射(ICSI;n=80)或胞浆内形态选择精子注射(IMSI;n=80)。比较 ICSI 和 IMSI 衍生胚胎的性别发生率。考虑到所有活检胚胎的性染色体均为正常,结果表明,与 ICSI 相比,IMSI 导致女性胚胎的发生率显著升高(分别为 65.1%和 54.0%,P=0.0277)。在仅分析 8 条染色体整倍体的胚胎后,也观察到 IMSI 衍生的 XX 胚胎的发生率明显高于 ICSI 周期(分别为 66.9%和 52.5%,P=0.0322)。逻辑回归证实了这一结果,表明高倍镜下选择的精子的整倍体 XX 胚胎的发生率增加近 2 倍(OR 1.83,95%CI 1.05-3.35,P=0.032)。高倍镜下分析的形态正常精子似乎携带 X 染色体的比例更高。本研究的目的是确定胞浆内形态选择精子注射(IMSI)的使用是否与性别发生率有关。由于高龄产妇,接受体外受精-胚胎植入前遗传筛查的夫妇被随机分配到两组:胞浆内单精子注射(ICSI;n=80)或胞浆内形态选择精子注射(IMSI;n=80)。比较 ICSI 和 IMSI 衍生胚胎的性别发生率。我们的结果显示,与 ICSI 周期相比,IMSI 衍生的女性胚胎的发生率显著升高(分别为 66.9%和 52.5%,P=0.0322)。逻辑回归证实了这一结果,表明高倍镜下选择的精子的整倍体 XX 胚胎的发生率增加近 2 倍(OR 1.83,95%CI 1.05-3.35,P=0.032)。高倍镜下分析的形态正常精子似乎携带 X 染色体的比例更高。